NEW YORK (GenomeWeb News) – Genetic testing startup Recombine said yesterday that it has raised $3.3 million in a Series A financing.

New York venture capital firm FirstMark Capital led the round, and other participants included Vast Ventures, Vivek Garipalli, Alexander Saint-Amand, as well as Flatiron Health Co-founders Zach Weinberg and Nat Turner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.